22Mar/13

600th Heart Attack Patient Recruited into Phase III CicloMulsion(R) CIRCUS Trial – PharmaLive (press release) (subscription)

600th Heart Attack Patient Recruited into Phase III CicloMulsion(R) CIRCUS Trial
PharmaLive (press release) (subscription)
NeuroVive, a leading mitochondrial medicine company, announces that the 600th patient has been recruited to a pivotal Phase III European, multi-center trial (CIRCUS trial) assessing CicloMulsion® (a special formulation of cyclosporine for acute cardiac

and more »

22Mar/13

600th Heart Attack Patient Recruited into Phase III CicloMulsion® CIRCUS Trial – PR Newswire UK (press release)

600th Heart Attack Patient Recruited into Phase III CicloMulsion® CIRCUS Trial
PR Newswire UK (press release)
NeuroVive, a leading mitochondrial medicine company, announces that the 600th patient has been recruited to a pivotal Phase III European, multi-center trial (CIRCUS trial) assessing CicloMulsion® (a special formulation of cyclosporine for acute cardiac

and more »